LD TECHNOLOGY
ABOUT US | HISTORY
LD TECHNOLOGY
ABOUT US | HISTORY
Patent numbers:
- US 9,668,701 B2
- US 10,383,565 B2
- US 9,629,559 B2
Clinical efficiency:
Clinical efficiency:
Published clinical studies demonstrate the clinical efficiency of our products. Our markers have been compared to the gold standards or for chronic care management. Our Studies returned a with high correlation with the gold standards as well as a high specificity and sensitivity to detect chronic diseases.
PTG mathematical analysis markers were compared to:
– Gold standard of Insulin resistance assessment:
Hyperinsulinemic Euglycemic Clamp (HEC), PTG-TP marker returns a sensitivity = 95.7%, specificity = 84,4% and the area under the ROC curve (AUC) = 0.929 for identifying insulin resistance.
– Oral Glucose Tolerance Test (OGTT):
The correlations between the OGTT and photoplethysmography index (PTGi) were: r = – 0.56 (p = 0.003) for glucose and r = – 0.41 (p = 0.04)for insulin
– Coronary angiography:
PTGi returns a sensitivity of 86.1% and specificity of 87.1% and the area under the ROC curve ( AUC) = 0.926 for identifying endothelial function.
OUR HISTORY
Dr. MAAREK worked with American engineers, designers, and PhDs at the University of Miami, as well as clinical investigators worldwide to develop a non-invasive point of care biosensors for manufacturing medical devices to help physicians in their daily practice.
WE DO IT
Because diabetes is not only a blood glucose concern, but also a chronic disease that damages the ANS and vascular functions.
Since the ANS and vascular system are damaged by an unhealthy lifestyle, and/or side-effects of current treatment, and/or aging, and/or chronic diseases like diabetes, LD products can evaluate these types of damage and provide major clinical data to physicians in order to improve patient outcomes.
In adjunct with lab tests , our products help physicians:
In adjunct with lab tests , our products help physicians:
1/ To diagnose the cause of symptoms, such as chronic pain, dizziness, fatigue, gastrointestinal disorders, exercise intolerance, heat intolerance, genitourinary disorders, hypoglycemia unawareness, claudication, etc…. Frequently, physicians encounter patients who have a chronic disease or other comorbid conditions and symptoms. At times, differentiating vascular from neuropathic disorders can be difficult. It is imperative to distinguish between autonomic neuropathy and vascular disease because the treatments are quite different. Our products offer the solution to this dilemma.
2/ For the early detection of complications related to chronic diseases, and/or aging, or side-effects of current treatment.
3/ For treatment management of metabolic syndrome, hypertension, diabetes, and cardiovascular disease.
4/ To motivate their patients to adopt healthier lifestyles.
“LD products provide physicians with major clinical data to improve patient outcomes and reduce overall costs in the healthcare system.”